Much of the scrutiny on so-called gender affirming care in the U.S. was made possible by the American medical establishment's own public recordings of practitioners candidly discussing the gruesome and lucrative nature of surgeries, hormone therapy and the lifelong medical management they require, and how to overcome parental opposition to child transitions. Perhaps the most oft-cited authority promoting puberty blockers, which the Food and Drug Administration has known increase suicidality since 2017, belatedly ensured a vocal critic of the organization couldn't get further ammunition to stir up trouble at its annual conference last week in Orlando, where the featured speaker...